Can’t Let Go: HHS Seeks To Overturn US Court Decision Striking Down DTC Ad Rule

The appeal is in keeping with the President Trump’s plan to stay active on drug pricing initiatives so he can claim victory on a key campaign promise.

Gavel
HHS Will Try To Prove It Has Authority For The Rule

If nothing else, the US Health and Human Services Department’s decision to appeal the recent court decision striking down its direct-to-consumer advertising rule shows how badly the Trump Administration wants to keep swinging in its battle to lower drug prices.

More from Pricing Debate

More from Market Access